129 related articles for article (PubMed ID: 29344240)
1. CXCL5 as an autocrine or paracrine cytokine is associated with proliferation and migration of hepatoblastoma HepG2 cells.
Yang Y; Hou J; Shao M; Zhang W; Qi Y; E S; Wang S; Sui H; Meng D; Wang B; Wang M; Han Y; Cao Y; Huang X; Li Y; Zhang P; Wang W
Oncol Lett; 2017 Dec; 14(6):7977-7985. PubMed ID: 29344240
[TBL] [Abstract][Full Text] [Related]
2. High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.
Qi Y; Zhao W; Li M; Shao M; Wang J; Sui H; Yu H; Shao W; Gui S; Li J; Jia X; Jiang D; Li Y; Zhang P; Wang S; Wang W
Int J Oncol; 2018 Jul; 53(1):358-370. PubMed ID: 29749439
[TBL] [Abstract][Full Text] [Related]
3. CXCL5 Plays a Promoting Role in Osteosarcoma Cell Migration and Invasion in Autocrine- and Paracrine-Dependent Manners.
Dang H; Wu W; Wang B; Cui C; Niu J; Chen J; Chen Z; Liu Y
Oncol Res; 2017 Jan; 25(2):177-186. PubMed ID: 28277189
[TBL] [Abstract][Full Text] [Related]
4. CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners.
Dai Z; Wu J; Chen F; Cheng Q; Zhang M; Wang Y; Guo Y; Song T
Oncol Rep; 2016 Dec; 36(6):3303-3310. PubMed ID: 27748886
[TBL] [Abstract][Full Text] [Related]
5. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
[TBL] [Abstract][Full Text] [Related]
6. [Expression and role of CXC chemokine 5 in liver cancer cells].
Xu XJ; Yang BW; Gong FX; Huang PX; Wu WZ; Xia JL
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(38):2716-9. PubMed ID: 23290114
[TBL] [Abstract][Full Text] [Related]
7. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.
Cui D; Zhao Y; Xu J
Biochimie; 2018 May; 148():1-11. PubMed ID: 29471001
[TBL] [Abstract][Full Text] [Related]
8. The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling.
Qiu WZ; Zhang HB; Xia WX; Ke LR; Yang J; Yu YH; Liang H; Huang XJ; Liu GY; Li WZ; Xiang YQ; Kang TB; Guo X; Lv X
J Exp Clin Cancer Res; 2018 Apr; 37(1):85. PubMed ID: 29665837
[TBL] [Abstract][Full Text] [Related]
9. Expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils.
Persson T; Monsef N; Andersson P; Bjartell A; Malm J; Calafat J; Egesten A
Clin Exp Allergy; 2003 Apr; 33(4):531-7. PubMed ID: 12680872
[TBL] [Abstract][Full Text] [Related]
10. Roles of CXCL5 on migration and invasion of liver cancer cells.
Xu X; Huang P; Yang B; Wang X; Xia J
J Transl Med; 2014 Jul; 12():193. PubMed ID: 25011526
[TBL] [Abstract][Full Text] [Related]
11. CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells.
Feng X; Zhang D; Li X; Ma S; Zhang C; Wang J; Li Y; Liang L; Zhang P; Qu Y; Zhang Z; Yang Z; Xiang Y; Zhang W; Wang S; Shao W; Wang W
Biomed Pharmacother; 2018 Nov; 107():1496-1504. PubMed ID: 30257367
[TBL] [Abstract][Full Text] [Related]
12. Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown.
Haarmann A; Schuhmann MK; Silwedel C; Monoranu CM; Stoll G; Buttmann M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704100
[TBL] [Abstract][Full Text] [Related]
13. CXC chemokine ligand 5 (CXCL5) disrupted the permeability of human brain microvascular endothelial cells via regulating p38 signal.
Yu M; Ma X; Jiang D; Wang L; Zhan Q; Zhao J
Microbiol Immunol; 2021 Jan; 65(1):40-47. PubMed ID: 33026667
[TBL] [Abstract][Full Text] [Related]
14. Serum CXCL5 level is associated with tumor progression in penile cancer.
Mo M; Li Y; Hu X
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33458757
[TBL] [Abstract][Full Text] [Related]
15. Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.
Ando Y; Ohuchida K; Otsubo Y; Kibe S; Takesue S; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Oda Y; Nakamura M
PLoS One; 2020; 15(1):e0228015. PubMed ID: 31999765
[TBL] [Abstract][Full Text] [Related]
16. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
Okabe H; Beppu T; Ueda M; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Mima K; Miyake K; Iwatsuki M; Baba Y; Takamori H; Jono H; Shinriki S; Ando Y; Baba H
Int J Cancer; 2012 Nov; 131(10):2234-41. PubMed ID: 22337081
[TBL] [Abstract][Full Text] [Related]
17. IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Hu Z; Luo D; Wang D; Ma L; Zhao Y; Li L
Cell Physiol Biochem; 2017; 43(6):2379-2390. PubMed ID: 29073625
[TBL] [Abstract][Full Text] [Related]
18. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
[TBL] [Abstract][Full Text] [Related]
19. CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells.
Wang L; Shi L; Gu J; Zhan C; Xi J; Ding J; Ge D
J Physiol Biochem; 2018 May; 74(2):313-324. PubMed ID: 29526026
[TBL] [Abstract][Full Text] [Related]
20. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
